TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 33782699

Group type: EXPERIMENTAL
Intervention: Quit messages referring to coronavirus
Number of subjects: 1509

Group type: EXPERIMENTAL
Intervention: Quit messages referring to risk of chest infection
Number of subjects: 1509

Group type: EXPERIMENTAL
Intervention: Quit messages encouraging cessation for financial reasons
Number of subjects: 1509

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 1509
Study: 35124183

Group type: EXPERIMENTAL
Intervention: Nivolumab (3 mg/kg every 2 weeks) plus ipilimumab (1 mg/kg every 6 weeks) for up to 2 years
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nivolumab plus ipilimumab
Number of subjects: 0

Group type: COMPARATOR
Intervention: Chemotherapy (six cycles of platinum plus pemetrexed)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Chemotherapy
Number of subjects: 0
Study: 34120925

Group type: EXPERIMENTAL
Intervention: Yoga intervention
Number of subjects: 26

Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 26
Study: 36321618

Group type: EXPERIMENTAL
Intervention: Infraclavicular block using peripheral nerve stimulation and ultrasonography
Number of subjects: 50
Study: 33382352

Group type: EXPERIMENTAL
Intervention: 500 mg of omega-3 supplementation
Number of subjects: 0

Group type: COMPARATOR
Intervention: 20 g of inulin (prebiotic) supplementation
Number of subjects: 0
Study: 32486840

Group type: EXPERIMENTAL
Intervention: Personalized audit and feedback intervention (monthly feedback for 6 months)
Number of subjects: 316

Group type: EXPERIMENTAL
Intervention: Guideline-concordant antibiotics (amoxicillin and azithromycin)
Number of subjects: 316

Group type: COMPARATOR
Intervention: Control group (no personalized feedback)
Number of subjects: 316
Study: 34038427

Group type: EXPERIMENTAL
Intervention: Fundamental Movement Skills (FMS)
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: Quality of Movement Patterns (QMP)
Number of subjects: 117

Group type: COMPARATOR
Intervention: Poor FMS
Number of subjects: 117

Group type: COMPARATOR
Intervention: Low QMP
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: Boys on object-control subtest and TGMD-2
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: Girls on FMS™
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: Correlation between MF, FMS, and QMP
Number of subjects: 117
Study: 33734768

Group type: EXPERIMENTAL
Intervention: Strength at Home Couples (SAH‐C) intervention
Number of subjects: 69

Group type: COMPARATOR
Intervention: Supportive Prevention
Number of subjects: 69
Study: 33080408

Group type: EXPERIMENTAL
Intervention: OncoScan CNV Plus Assay (OS+)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Sanger sequencing
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Updated OS+ algorithm
Number of subjects: 46
Study: 32097058

Group type: EXPERIMENTAL
Intervention: Ultrasound visual feedback (UVF)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Auditory perceptual training plus UVF
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 38
Study: 34045222

Group type: EXPERIMENTAL
Intervention: Continuation of PGA therapy after cataract surgery (CPGA)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Discontinuation of PGA therapy
Number of subjects: 62
Study: 33439974

Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 544

Group type: COMPARATOR
Intervention: Sevoflurane
Number of subjects: 544

Group type: EXPERIMENTAL
Intervention: High blood interleukin-6 concentration at 1 hour after skin incision
Number of subjects: 544
Study: 35418429

Group type: EXPERIMENTAL
Intervention: Low-intensity brisk walking
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Medium-intensity brisk walking
Number of subjects: 0
Study: 33745587

Group type: EXPERIMENTAL
Intervention: Micronutrient supplementation protocol in Leuven: commercial vitamins, trace elements, and electrolytes in separate infusions over 4 hours.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Micronutrient supplementation protocol in Rotterdam: commercial vitamins and trace elements via 8-hour infusion and electrolytes continuously over 24 hours.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Micronutrient supplementation protocol in Edmonton: commercial vitamins and institutionally prepared trace elements solutions in 1 hour and electrolytes on demand.
Number of subjects: 0
Study: 32125256

Group type: EXPERIMENTAL
Intervention: Paclitaxel drug-coated balloon (DCB) angioplasty
Number of subjects: 171

Group type: COMPARATOR
Intervention: Conventional balloon angioplasty
Number of subjects: 171
Study: 35777921

Group type: EXPERIMENTAL
Intervention: InSpace implant
Number of subjects: 184

Group type: COMPARATOR
Intervention: Partial repair
Number of subjects: 184
Study: 33636568

Group type: EXPERIMENTAL
Intervention: Oxygen hoods/helmets
Number of subjects: 136

Group type: COMPARATOR
Intervention: Conventional high-flow oxygen delivery systems
Number of subjects: 136
Study: 36290890

Group type: EXPERIMENTAL
Intervention: 8-week exercise program
Number of subjects: 11

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 11
Study: 34571624

Group type: EXPERIMENTAL
Intervention: Mitomycin C
Number of subjects: 93

Group type: COMPARATOR
Intervention: Ologen implant
Number of subjects: 93
Study: 34750705

Group type: EXPERIMENTAL
Intervention: Lidocaine spray in sitting position (Group A)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lidocaine spray in supine position (Group B)
Number of subjects: 0
Study: 33814231

Group type: EXPERIMENTAL
Intervention: 3-dose 20 μg recombinant hepatitis B vaccine
Number of subjects: 352

Group type: EXPERIMENTAL
Intervention: 3-dose 60 μg recombinant hepatitis B vaccine
Number of subjects: 352

Group type: EXPERIMENTAL
Intervention: Peak anti-HBs levels in 100–1000 mIU/mL or ≥ 1000 mIU/mL
Number of subjects: 352

Group type: EXPERIMENTAL
Intervention: Kinetic profile of anti-HBs levels
Number of subjects: 352
Study: 33136781

Group type: EXPERIMENTAL
Intervention: Probiotic i3.1
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study: 32970558

Group type: EXPERIMENTAL
Intervention: Barrier enclosure
Number of subjects: 50

Group type: COMPARATOR
Intervention: No barrier
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Practice barrier enclosure
Number of subjects: 50
Study: 34478381

Group type: EXPERIMENTAL
Intervention: Block-local circular convolution binding
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Random projection based binding
Number of subjects: 0
Study: 33263183

Group type: EXPERIMENTAL
Intervention: Elevated body mass index (BMI)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 34672847

Group type: EXPERIMENTAL
Intervention: Mirabegron 50 mg
Number of subjects: 110

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 110
Study: 32593592

Group type: EXPERIMENTAL
Intervention: Thromboembolic prophylaxis
Number of subjects: 72

Group type: COMPARATOR
Intervention: Not starting medication
Number of subjects: 72
Study: 35729762

Group type: EXPERIMENTAL
Intervention: Low dose FIO₂ of 30%, 40%, 50%, and 100% (Arm 1)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: High dose FIO₂ of 60%, 70%, 80%, and 100% (Arm 2)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: 100% FIO₂ (both Arm 1 and Arm 2)
Number of subjects: 26
Study: 32721210

Group type: EXPERIMENTAL
Intervention: Immediate Bronchial Thermoplasty (BT) treatment (n=20)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Delayed control group (n=20)
Number of subjects: 40
Study: 32792131

Group type: EXPERIMENTAL
Intervention: Bupivacaine (0.25%)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo (0.9% saline)
Number of subjects: 14
Study: 36047578

Group type: EXPERIMENTAL
Intervention: The Growth Factory (TGF) intervention
Number of subjects: 119

Group type: COMPARATOR
Intervention: Passive control group
Number of subjects: 119
Study: 33044490

Group type: EXPERIMENTAL
Intervention: Self-taken pooled samples
Number of subjects: 1793

Group type: COMPARATOR
Intervention: Clinician triple samples
Number of subjects: 1793

Group type: COMPARATOR
Intervention: Vulvovaginal swabs (VVS) and first-catch urine (FCU) testing alone
Number of subjects: 1793
Study: 34234141

Group type: EXPERIMENTAL
Intervention: cfSNV method for detecting low-frequency mutations from cfDNA
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: cfSNV method
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: cfSNV tumor mutation profile from cfDNA WES data
Number of subjects: 0
Study: 33099503

Group type: EXPERIMENTAL
Intervention: Open-loop decision support system
Number of subjects: 0

Group type: COMPARATOR
Intervention: Routine care
Number of subjects: 0
Study: 33201085

Group type: EXPERIMENTAL
Intervention: EQ-5D 3L value set
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: EQ-5D 5L value set
Number of subjects: 0
Study: 35533737

Group type: EXPERIMENTAL
Intervention: Inspiratory Muscle Training (IMT)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Aerobic exercise training
Number of subjects: 40
Study: 34563277

Group type: EXPERIMENTAL
Intervention: Matrix-M-adjuvanted quadrivalent nanoparticle influenza vaccine (qNIV)
Number of subjects: 2654

Group type: COMPARATOR
Intervention: Quadrivalent inactivated influenza vaccine (IIV4)
Number of subjects: 2654
Study: 32057673

Group type: EXPERIMENTAL
Intervention: Low-dose HCG from Day 7 until at least three follicles reached 17 mm or more
Number of subjects: 105

Group type: COMPARATOR
Intervention: Conventional ovarian stimulation with highly purified HMG injections
Number of subjects: 105
Study: 34130595

Group type: EXPERIMENTAL
Intervention: Motivational interviewing
Number of subjects: 255

Group type: COMPARATOR
Intervention: Health education and brief advice
Number of subjects: 255
Study: 32109194

Group type: EXPERIMENTAL
Intervention: Concurrent rituximab (375 mg/m2) with cladribine (0.15 mg/kg)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Cladribine monotherapy
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Delayed rituximab after cladribine
Number of subjects: 68
Study: 36053717

Group type: EXPERIMENTAL
Intervention: Vitamin E 200 IU
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Curcumin 500 mg
Number of subjects: 84

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 84
Study: 34376554

Group type: EXPERIMENTAL
Intervention: Atezolizumab followed by sipuleucel-T (Arm 1)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Sipuleucel-T followed by atezolizumab (Arm 2)
Number of subjects: 37
Study: 616119287

Group type: EXPERIMENTAL
Intervention: Retixoft (300 mg alpha-lipoic acid, 1.1 mg vitamin B1, 1.4 mg vitamin B2, 25 mg rutoside) for 3 months
Number of subjects: 80

Group type: COMPARATOR
Intervention: No Retixoft supplementation (Control)
Number of subjects: 80
Study: 34348079

Group type: EXPERIMENTAL
Intervention: mRPQ (modified Rivermead Post-concussion Symptoms Questionnaire)
Number of subjects: 298
Study: 34329333

Group type: EXPERIMENTAL
Intervention: Informal provider as first contact
Number of subjects: 255

Group type: EXPERIMENTAL
Intervention: Weight loss as a presenting symptom
Number of subjects: 255

Group type: EXPERIMENTAL
Intervention: Fatigue as a presenting symptom
Number of subjects: 255

Group type: EXPERIMENTAL
Intervention: Underweight BMI category
Number of subjects: 255

Group type: EXPERIMENTAL
Intervention: Good knowledge about TB
Number of subjects: 255
Study: 32942102

Group type: EXPERIMENTAL
Intervention: Liquid chromatography quadrupole time‐of‐flight mass spectrometry method for tryptophan and kynurenine determination
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Liquid chromatography quadrupole time‐of‐flight mass spectrometry method
Number of subjects: 0
Study: 36400636

Group type: EXPERIMENTAL
Intervention: Family-centered communication
Number of subjects: 108
Study: 34049484

Group type: EXPERIMENTAL
Intervention: Galcanezumab 120 mg
Number of subjects: 1773

Group type: EXPERIMENTAL
Intervention: Galcanezumab 240 mg
Number of subjects: 1773

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1773

Group type: EXPERIMENTAL
Intervention: Galcanezumab 120 mg and 240 mg
Number of subjects: 1773
Study: 32723736

Group type: EXPERIMENTAL
Intervention: Motivational interviewing (MI) counselling sessions, approximately 10 sessions (4 in-person with Ped/NP and up to 6 telephonic with a trained RD) over about 2 years.
Number of subjects: 24

Group type: COMPARATOR
Intervention: Usual care (training in billing/coding and study procedures only).
Number of subjects: 24
Study: 36145549

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5583
Study: 34672925

Group type: EXPERIMENTAL
Intervention: Augmented Reality Exposure Therapy (ARET)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Waitlist Control
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: ARET
Number of subjects: 25
Study: 35979404

Group type: EXPERIMENTAL
Intervention: Dog-assisted intervention
Number of subjects: 169

Group type: EXPERIMENTAL
Intervention: Relaxation intervention
Number of subjects: 169

Group type: COMPARATOR
Intervention: No treatment control group
Number of subjects: 169
Study: 32542878

Group type: EXPERIMENTAL
Intervention: Direct Oral Anticoagulants (DOACs)
Number of subjects: 959

Group type: EXPERIMENTAL
Intervention: Vitamin K Antagonists (VKAs)
Number of subjects: 959

Group type: COMPARATOR
Intervention: No anticoagulation
Number of subjects: 959
Study: 35588200

Group type: EXPERIMENTAL
Intervention: Patients enrolled during COVID-19 (n=191)
Number of subjects: 856

Group type: COMPARATOR
Intervention: Patients enrolled pre-COVID-19 (n=665)
Number of subjects: 856

Group type: EXPERIMENTAL
Intervention: Unmarried patients during COVID-19
Number of subjects: 856

Group type: COMPARATOR
Intervention: Unmarried patients pre-COVID-19
Number of subjects: 856
Study: 35568336

Group type: EXPERIMENTAL
Intervention: Laser peripheral iridotomy (LPI) in one randomly selected eye
Number of subjects: 889

Group type: COMPARATOR
Intervention: Untreated control (fellow eye)
Number of subjects: 889
Study: 33538822

Group type: EXPERIMENTAL
Intervention: Firearm involvement during adolescence (use, access, victimization)
Number of subjects: 1829

Group type: EXPERIMENTAL
Intervention: Victimization (threatened with a weapon or gunshot injury) during adolescence
Number of subjects: 1829

Group type: EXPERIMENTAL
Intervention: Victimization (gunshot injury) during adolescence
Number of subjects: 1829

Group type: EXPERIMENTAL
Intervention: Firearm involvement during adolescence
Number of subjects: 1829
Study: 36167553

Group type: EXPERIMENTAL
Intervention: Donepezil
Number of subjects: 78

Group type: COMPARATOR
Intervention: Control
Number of subjects: 78
Study: 32564066

Group type: EXPERIMENTAL
Intervention: Intensive lifestyle intervention (ILI)
Number of subjects: 4859

Group type: COMPARATOR
Intervention: Diabetes support and education (DSE)
Number of subjects: 4859
Study: 32160798

Group type: EXPERIMENTAL
Intervention: Cognitive behavioral group intervention
Number of subjects: 38

Group type: COMPARATOR
Intervention: Active waiting time protocol (Control)
Number of subjects: 38
Study: 35114384

Group type: EXPERIMENTAL
Intervention: Spironolactone initiation
Number of subjects: 621171

Group type: EXPERIMENTAL
Intervention: Spironolactone initiators
Number of subjects: 621171
Study: 33713622

Group type: EXPERIMENTAL
Intervention: HaRT-A plus XR-NTX
Number of subjects: 308

Group type: EXPERIMENTAL
Intervention: HaRT-A plus placebo
Number of subjects: 308

Group type: EXPERIMENTAL
Intervention: HaRT-A alone
Number of subjects: 308

Group type: COMPARATOR
Intervention: services-as-usual control
Number of subjects: 308
Study: 35264104

Group type: EXPERIMENTAL
Intervention: TENS (transcutaneous electrical nerve stimulation) applied with a pulse width of 385 μs and a frequency of 10 Hz for 30 min.
Number of subjects: 30

Group type: COMPARATOR
Intervention: Sham treatment without stimulation.
Number of subjects: 30
Study: 33813536

Group type: EXPERIMENTAL
Intervention: Simulation program (four-scenario simulation)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 43
Study: 36239289

Group type: EXPERIMENTAL
Intervention: Interval-walking training (IWT)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Control group (non-intervention)
Number of subjects: 55
Study: 35896768

Group type: EXPERIMENTAL
Intervention: Targeted Temperature Management (TTM) at 33 °C
Number of subjects: 950

Group type: COMPARATOR
Intervention: Targeted Temperature Management (TTM) at 36 °C
Number of subjects: 950

Group type: EXPERIMENTAL
Intervention: Sedation and analgesia dosing and titration
Number of subjects: 950
Study: 32838539

Group type: EXPERIMENTAL
Intervention: Telehealth cognitive behavioral therapy for insomnia (CBT‐CI)
Number of subjects: 0
Study: 32962677

Group type: EXPERIMENTAL
Intervention: Autonomy supportive intervention delivered by PE teachers
Number of subjects: 502
Study: 35576853

Group type: EXPERIMENTAL
Intervention: Traditional Thai massage (TTM)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Thai boxing exercise (TBE)
Number of subjects: 78
Study: 33768520

Group type: EXPERIMENTAL
Intervention: Oral misoprostol
Number of subjects: 1213
Study: 32584425

Group type: EXPERIMENTAL
Intervention: Antiparasitic treatment with albendazole
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 35536347

Group type: EXPERIMENTAL
Intervention: Voice-based delivery system of the PHQ 9 using Amazon Alexa
Number of subjects: 41

Group type: COMPARATOR
Intervention: Paper version of the PHQ 9
Number of subjects: 41
Study: 36346956

Group type: EXPERIMENTAL
Intervention: WBT-lifestyle intervention
Number of subjects: 58
Study: 32720469

Group type: EXPERIMENTAL
Intervention: Routine vitamin A supplementation (VAS)
Number of subjects: 855

Group type: EXPERIMENTAL
Intervention: Albendazole for deworming
Number of subjects: 855

Group type: EXPERIMENTAL
Intervention: Complementary feeding practices
Number of subjects: 855

Group type: EXPERIMENTAL
Intervention: Family planning services
Number of subjects: 855
Study: 37352528

Group type: EXPERIMENTAL
Intervention: Neoadjuvant intensity modulated radiation therapy (18 Gy with fractionated doses of 3 Gy) followed by surgery 4 weeks later
Number of subjects: 60

Group type: COMPARATOR
Intervention: Upfront surgery
Number of subjects: 60
Study: 33808137

Group type: EXPERIMENTAL
Intervention: Wrist stabilization exercise + taping therapy (WSE + TT)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Wrist stabilization exercise (WSE)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control group (passive range of motion exercise)
Number of subjects: 45
Study: 36093704

Group type: EXPERIMENTAL
Intervention: Micronutritional supplementation (1g fish oil with 500mg DHA, 150mg EPA; 22mg carotenoids including 10mg lutein, 10mg meso-zeaxanthin, 2mg zeaxanthin; 15mg vitamin E)
Number of subjects: 77

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Micronutritional supplementation
Number of subjects: 77
Study: 33525659

Group type: EXPERIMENTAL
Intervention: ELOVL5‐Mo
Number of subjects: 3

Group type: COMPARATOR
Intervention: Technical control Mo
Number of subjects: 3

Group type: COMPARATOR
Intervention: Biological control
Number of subjects: 3
Study: 32384502

Group type: EXPERIMENTAL
Intervention: High tone external muscle stimulation therapy (HTEMS)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Transcutaneous electrical nerve stimulation (TENS)
Number of subjects: 50
Study: 35217858

Group type: EXPERIMENTAL
Intervention: Personalized feedback intervention (PFI) regarding social network presence during drinking occasions
Number of subjects: 338

Group type: COMPARATOR
Intervention: Control group (no feedback)
Number of subjects: 338
Study: 36060231

Group type: EXPERIMENTAL
Intervention: Changes in maternal emotion regulation (ER)
Number of subjects: 77
Study: 35085038

Group type: EXPERIMENTAL
Intervention: Whole Pelvic Radiation Therapy (WPRT)
Number of subjects: 28724

Group type: COMPARATOR
Intervention: Prostate-only radiotherapy
Number of subjects: 28724
Study: 33413210

Group type: EXPERIMENTAL
Intervention: Capsular tension ring (CTR) implantation
Number of subjects: 42

Group type: COMPARATOR
Intervention: Control (no CTR implantation)
Number of subjects: 42
Study: 32151020

Group type: EXPERIMENTAL
Intervention: Dietary fiber intake in patients with NAFLD
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: NAFLD patients
Number of subjects: 63

Group type: COMPARATOR
Intervention: Controls
Number of subjects: 63
Study: 35679202

Group type: EXPERIMENTAL
Intervention: web-delivered alcohol-linked attentional bias modification (AtBM)
Number of subjects: 43

Group type: COMPARATOR
Intervention: sham-training (control)
Number of subjects: 43
Study: 34934964

Group type: EXPERIMENTAL
Intervention: Screening group (PSA screening)
Number of subjects: 241234

Group type: COMPARATOR
Intervention: Control group (no screening)
Number of subjects: 241234

Group type: EXPERIMENTAL
Intervention: Both arms combined
Number of subjects: 241234
Study: 36192092

Group type: EXPERIMENTAL
Intervention: Magnetic resonance enterography (MRE) features at diagnosis
Number of subjects: 0
Study: 32229668

Group type: EXPERIMENTAL
Intervention: VIB (vibration protocol)
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: SWI (regular swimming training)
Number of subjects: 109

Group type: COMPARATOR
Intervention: CON (normoactive controls)
Number of subjects: 109
Study: 35725020

Group type: EXPERIMENTAL
Intervention: Exenatide
Number of subjects: 0

Group type: COMPARATOR
Intervention: Insulin
Number of subjects: 0
Study: 32572100

Group type: EXPERIMENTAL
Intervention: Blended CPR training program (18‐minute e‐learning plus 30‐minute hands‐on)
Number of subjects: 832

Group type: COMPARATOR
Intervention: Traditional CPR training program
Number of subjects: 832

Group type: EXPERIMENTAL
Intervention: Blended CPR training program
Number of subjects: 832
Study: 33524208

Group type: EXPERIMENTAL
Intervention: Mobile application (genitalsystem.apk)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Standard curriculum (control group)
Number of subjects: 63
Study: 34335138

Group type: EXPERIMENTAL
Intervention: Newborn screening for sickle cell disease and trait
Number of subjects: 10529

Group type: EXPERIMENTAL
Intervention: Newborn screening for alpha thalassemia trait
Number of subjects: 10529

Group type: EXPERIMENTAL
Intervention: Newborn screening for G6PD deficiency
Number of subjects: 10529
Study: 36100406

Group type: EXPERIMENTAL
Intervention: Respiratory mechanics-guided sedation strategy (dexmedetomidine combined with propofol)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Light sedation (control group)
Number of subjects: 90
Study: 35650559

Group type: EXPERIMENTAL
Intervention: Simulation-based medical education (SBME)
Number of subjects: 190

Group type: EXPERIMENTAL
Intervention: Simulation-based medical education combined with behavioural economics (SBME + BE)
Number of subjects: 190

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 190